HIGHLIGHTS
- who: Fuzhen Wang from the National Institute of Health (ISS), Italy Hacettepe University, Turkey have published the paper: Factors associated with neutralizing antibody levels induced by two inactivated COVID-19 vaccines for 12 months after primary series vaccination, in the Journal: (JOURNAL)
- what: Trained staff called potentiallyeligible subjects and explained the study purpose, protocol, implementation process, information and specimen collection procedures, and risks and benefits over the phone. This study demonstrated that the AZD1222 vaccine efficacy of 80% against symptomatic infection with B.1.1.7 variant of SARS-CoV-2 was achieved with 26 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.